Massachusetts Financial Services Co. MA Sells 125,734 Shares of Danaher Corporation $DHR

Massachusetts Financial Services Co. MA reduced its position in Danaher Corporation (NYSE:DHR) by 5.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,252,843 shares of the conglomerate’s stock after selling 125,734 shares during the quarter. Massachusetts Financial Services Co. MA owned 0.31% of Danaher worth $445,027,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Red Tortoise LLC lifted its position in shares of Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares during the period. Costello Asset Management INC bought a new position in Danaher in the first quarter worth approximately $41,000. Ramirez Asset Management Inc. purchased a new stake in Danaher during the second quarter worth $40,000. Mowery & Schoenfeld Wealth Management LLC boosted its position in Danaher by 53.8% during the 1st quarter. Mowery & Schoenfeld Wealth Management LLC now owns 203 shares of the conglomerate’s stock valued at $42,000 after acquiring an additional 71 shares in the last quarter. Finally, Strengthening Families & Communities LLC increased its holdings in shares of Danaher by 81.4% in the 1st quarter. Strengthening Families & Communities LLC now owns 254 shares of the conglomerate’s stock valued at $52,000 after acquiring an additional 114 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Up 0.0%

Danaher stock opened at $221.25 on Friday. The business’s 50-day simple moving average is $205.63 and its two-hundred day simple moving average is $201.10. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. The company has a market cap of $156.28 billion, a PE ratio of 45.62, a PEG ratio of 3.28 and a beta of 0.81. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $258.23.

Danaher (NYSE:DHR) last released its earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the previous year, the company posted $1.71 earnings per share. The company’s revenue was up 4.4% compared to the same quarter last year. Equities analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, September 26th. Danaher’s dividend payout ratio is 26.39%.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Redburn Partners set a $220.00 target price on shares of Danaher in a report on Wednesday, October 8th. UBS Group cut their price objective on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research report on Wednesday, July 23rd. Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a research report on Wednesday, October 8th. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Monday, November 10th. Finally, Evercore ISI upped their price target on Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Eighteen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $243.39.

Insider Buying and Selling

In related news, SVP Georgeann Couchara sold 5,174 shares of the business’s stock in a transaction on Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the transaction, the senior vice president directly owned 2,625 shares in the company, valued at $552,352.50. The trade was a 66.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Teri List sold 2,778 shares of the company’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 29,728 shares of company stock valued at $6,448,990 over the last 90 days. Insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.